Applied Pharmaceutical Practice and Nutraceuticals Natural Product Development

1. Chalcone (1, 3-Diphenyl-2-Propene-1-One) Scaffold Bearing Natural Compounds as Nitric Oxide Inhibitors: Promising Anti-Edema Agents 2. Emblicanin-A and Emblicanin-B: Pharmacological and Nano-Pharmacotherapeutic Perspective for Healthcare Applications 3. Recent In-Depth Insights of Nature-Based Anti-Worm Therapeutic Medications: Emerging Herbal Anthelmintics 4. Insights into the Recent Scientific Evidences of Natural Therapeutic Treasures as Diuretic Agents 5. Reviewing the Available Herbal Resources for Treating Psoriasis: Safe and Alternative Way for Therapeutics 6. Nutraceuticals and Brain Disorders 7. 1, 3-Diphenyl-2-Propene-1-One Based Natural Product Anti-Diabetic Molecules as Inhibitors of Protein Tyrosine Phosphatase-1b (Ptp-1b) 8. Re-Highlighting the Potential Natural Resources for Treating or Managing the Ailments of Gastrointestinal Tract Origin 9. Recent Advancements of Curcumin Analogs and Curcumin Formulations in Context to Modern Pharmacotherapeutics Perspectives 10. Emerging Highlights on Natural Prodrug Molecules with Multifarious Therapeutic Perspectives 11. Perspectives of Nature-Oriented Pharmacotherapeutics for the Effectual Management of Hemorrhoidal Symptoms 12. Effect of Light on Transport of Potassium Thiocyanate in Aqueous Solutions: Part 1 13. Drug Discovery, Drug Likeness Screening and Bioavailability: Development of Drug-Likeness Rule for Natural Products 14. Biomolecular and Molecular Docking: A Modern Tool in Drug Discovery and Virtual Screening of Natural Products

Debarshi Kar Mahapatra, PhD, is Assistant Professor in the Department of Pharmaceutical Chemistry at Dadasaheb Balpande College of Pharmacy, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, Maharashtra, India. He was formerly Assistant Professor in the Department of Pharmaceutical Chemistry, Kamla Nehru College of Pharmacy, RTM Nagpur University, Nagpur, India. He has published research, book chapters, reviews, and case studies in various reputed journals and has presented his work on several international platforms, for which he has received several important awards by a number of bodies. He has also authored the book titled Drug Design. Presently, he is serving as a reviewer and editorial board member for several journals of international repute.
Cristóbal Noé Aguilar, PhD, is Director of Research and Postgraduate Programs at the Universidad Autonoma de Coahuila, Mexico. Dr. Aguilar has published more than 160 papers in indexed journals, more than 40 articles in Mexican journals, and 250 contributions in scientific meetings. He has also published many book chapters, several Mexican books, four editions of international books, and more. He has been awarded several prestigious prizes and awards for his work. Dr. Aguilar is a member of the Mexican Academy of Science, the International Bioprocessing Association, Mexican Academy of Sciences, Mexican Society for Biotechology and Bioengineering, and the Mexican Association for Food Science and Biotechnology. He has developed more than 21 research projects, including six international exchange projects.
A. K. Haghi, PhD, is the author and editor of over 200 books, as well as over 1000 published papers in various journals and conference proceedings. Dr. Haghi has received several grants, consulted for a number of major corporations, and is a frequent speaker to national and international audiences. Since 1983, he served as professor at several uni